Ghani Chemical Industries Proposes Rs 1.16 billion Rights Issue to Fund Three New Projects
GCIL (PSX: GCIL) seeks shareholder approval for a rights issue that could raise up to Rs 1.16 billion, earmarked for equity investment in the Silo Lashari, Jandran and Maiwand projects, part of a Rs 6.02 billion expansion plan.
Share
Desk Analysis
How This Affects the Exchange
Sector Effect
Positive · Buy bias
Fertilizer sector and GCIL likely benefit from expansion funding; Buy bias on GCIL.
Sectors & Direction
Desk read
Desk call: Buy bias · Positively affected
- FertilizerPositively affected
Companies
Companies Mentioned
- GCIL· Positively affected · Buy bias
Mentions in This Briefing
Sectors: Fertilizer — Positive · Buy bias. PSX tickers: GCIL. Fertilizer sector and GCIL likely benefit from expansion funding; Buy bias on GCIL.
Full Story
Open on ProPakistani## Rights Issue Proposal
Ghani Chemical Industries Limited (PSX: GCIL) announced a board‑approved proposal to issue up to 116,374,900 Class B tracking shares at Rs 10 each, targeting a maximum raise of Rs 1,163,749,000. The issue would represent roughly 20.4 % of the company’s current paid‑up ordinary share capital of 570,451,931 shares. Eligible shareholders would receive one tracking share for every 1,000 ordinary shares they hold, pending final entitlement ratios and regulatory clearances.
## Use of Proceeds
The capital raised is intended to fund GCIL’s equity stake in three new projects – Silo Lashari, Jandran and Maiwand – whose total estimated cost is about Rs 6.02 billion. The financing plan combines project debt of roughly Rs 4 billion with project equity of Rs 2.01 billion. Of the equity portion, Rs 1.16 billion will come from the rights issue, while the remaining Rs 850 million will be sourced from internal reserves.
## Strategic Rationale
GCIL says the projects will support its expansion and diversification strategy, giving the company exposure to potential earnings and distributions from the new assets, subject to required approvals and agreements. The rights issue remains contingent on shareholder approval, amendments to authorized share capital, and completion of all regulatory and contractual formalities.
## Market Implications
If approved, the infusion of capital could strengthen GCIL’s balance sheet and enable growth in the fertilizer and chemical segments, which may positively influence related sector performance on the PSX.